SCHEMBL4337637

SCHEMBL4337637

O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1F)c1ccco1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.45
HSD17B10 Q99714 2/20 0.45
TSHR P16473 2/20 0.45
USP2 O75604 1/20 0.45
TP53 P04637 1/20 0.45
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 6/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RAB9A P51151 8/20 0.43
NPC1 O15118 7/20 0.43
MAPK10 P53779 1/20 0.42
KMT2A Q03164 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 3/20 0.42
ESR2 Q92731 1/20 0.42
ITK Q08881 1/20 0.42
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342242 0.87 HSD17B10 (0.43) MAPK1HSD17B10TSHRUSP2TP53
SCHEMBL4337651 0.84 MAPK10 (0.46) MAPK1HSD17B10TSHRUSP2TP53
SCHEMBL4329385 0.83 STK33 (0.44) TDP1MAPTRAB9ANPC1MAPK10
SCHEMBL4329234 0.82 MAPT (0.44) MAPK1HSD17B10TSHRTP53TDP1
SCHEMBL4334435 0.81 KMT2A (0.47) HSD17B10TSHRTP53ATMMAPT
SCHEMBL4343158 0.80 MAPK10 (0.54) RAB9ANPC1MAPK10ITKMAPKAPK2
SCHEMBL2862233 0.79 MEN1 (0.45) HSD17B10TSHRTP53MAPTRAB9A
SCHEMBL4343390 0.78 HPGD (0.45) MAPK1HSD17B10TSHRTP53TDP1
SCHEMBL4334983 0.77 MAPK10 (0.49) MAPK1HSD17B10TSHRTP53RAB9A
SCHEMBL2861026 0.76 TNIK (0.49) MAPK10ITKMAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK1 1/4885HSD17B10 1699/4885TSHR 2121/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPK1 1/4885HSD17B10 1699/4885TSHR 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.